Lindis Biotech GmbH | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
Lindis Biotech GmbH

BRIEF

published on 11/19/2024 at 10:12, 1 day 23 hours ago

LINDIS Biotech Partners with Pharmanovia for Catumaxomab Launch

Cancer Therapy Malignant Ascites Catumaxomab LINDIS Biotech Pharmanovia
BRIEF

published on 11/19/2024 at 10:12, 1 day 23 hours ago

LINDIS Biotech s'associe à Pharmanovia pour le lancement du Catumaxomab

Thérapie Contre Le Cancer Catumaxomab Ascite Maligne LINDIS Biotech Pharmanovia
PRESS RELEASE

published on 11/19/2024 at 10:07, 1 day 23 hours ago

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab
LINDIS Biotech signs licensing agreement with Pharmanovia for the commercialization of Catumaxomab, a trifunctional bi-specific monoclonal antibody for malignant ascites treatment

Licensing Agreement Malignant Ascites Catumaxomab LINDIS Biotech Pharmanovia
BRIEF

published on 10/21/2024 at 09:05, 1 month ago

LINDIS Biotech Achieves Key Milestone for Cancer Treatment in Europe

European Commission CHMP Approval KORJUNY® Malignant Ascites Catumaxomab
BRIEF

published on 10/21/2024 at 09:05, 1 month ago

LINDIS Biotech franchit une étape clé dans le traitement du cancer en Europe

Commission Européenne KORJUNY® Catumaxomab Approbation Du CHMP Ascite Maligne
PRESS RELEASE

published on 10/21/2024 at 09:00, 1 month ago

LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union
LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union, becoming the only drug approved for intraperitoneal treatment of malignant ascites in adults with EpCAM-positive carcinomas

CHMP Opinion Malignant Ascites Catumaxomab LINDIS Biotech KORJUNY

Accesswire

Published on 11/21/2024 at 09:00, 37 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 2 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 12 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 37 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 37 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 36 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 37 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 37 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 22 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 27 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 30 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 17 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE